Plain-English translation of NCT07473804 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This is a research study that looks back at medical records of newborns who were treated for salt loss โ a serious condition where babies lose too much salt from their bodies โ at a specialized medical center in Italy. The study focuses on rare genetic causes of salt loss that are not the most common type (21-hydroxylase deficiency). By studying these cases, researchers hope to better understand how often these rare conditions occur, what symptoms to look for, and how to treat them.
Most newborn screening programs in Italy detect only the most common genetic cause of salt loss, but several other rare genetic disorders can cause the same dangerous condition in newborns. This study exists to figure out how many babies actually have these other rare causes, so doctors can recognize and treat them faster and save lives.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
Participation is straightforward โ you would give permission for researchers to review your child's medical records, including blood test results, hospital notes, and genetic test results from their time at the medical center. There are no visits, injections, or new treatments involved. This is purely a data review study to help doctors learn more about these rare conditions.
AI-generated summary from trial data ยท Oct 7, 2026 ยท Not medical advice
Italy
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Enrollment target
~25 participants
Started
April 2025
Primary completion
December 2026
Age range
1 Year โ 35 Years
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary โ some teams are faster than others.
Central contact
Federico Baronio
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first โ no email needed to get started.